Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Dermoscopy × Clear all

Status

Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Nevus 1 Melanoma 1 Margins of Excision 1 Dysplastic Nevus Syndrome 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 47 pembrolizumab 46 Ipilimumab 26 Cyclophosphamide 13 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 Opdualag 9 fludarabine 8 Biopsy 8 relatlimab 7 binimetinib 7 Blood Specimen Collection 7 aldesleukin 6 Interleukin-2 6 encorafenib 5 cemiplimab 5 Paclitaxel 5 Bevacizumab 5 atezolizumab 4 Immunotherapy 4 CTLA-4 Antigen 4 trametinib 3 toripalimab 3 spartalizumab 3 dabrafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Standard of Care 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡